Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026
Go back to Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026| (NASDAQ: ASMB) | Delayed: 24.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.44 | 52 Week High | $14.50 | |||
| Open | $24.44 | 52 Week Low | $4.33 | |||
| Day High | $24.44 | P/E | N/A | |||
| Day Low | $24.44 | EPS | $0.00 | |||
| Volume | 159 | |||||

